The current pharmacotherapy for AD involves the usage of acetylcholinesterase (donepezil, rivastigmine, and galantamine) and NMDA glutamate (memantine) inhibitors, both of which only provide symptomatic relief along with several side effects (Anand et al., 2017b). Here, ACHE is linked to Alzheimer disease.